Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Accretion Pharmaceuticals Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Accretion Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Accretion Pharma - Action(s) taken or orders passed

    7 Jan 2026, 5:47PM Accretion Pharmaceuticals Limited has informed the Exchange about Action(s) taken or orders passed
  • Accretion Pharma - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

    3 Jan 2026, 6:00PM Accretion Pharmaceuticals Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q3 FY 2025-26
  • Accretion Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    2 Jan 2026, 5:30PM Accretion Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    8 Dec 2025, 10:27PM Accretion Pharmaceuticals Limited has informed the Exchange about Schedule of meet
  • Accretion Pharma - General Updates

    27 Nov 2025, 4:06PM Accretion Pharmaceuticals Limited has informed the Exchange about General Updates
  • Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    26 Nov 2025, 3:42PM Accretion Pharmaceuticals Limited has informed the Exchange about Schedule of meet
  • Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    26 Nov 2025, 3:39PM Accretion Pharmaceuticals Limited has informed the Exchange about Schedule of meet
  • Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    24 Nov 2025, 7:06PM Accretion Pharmaceuticals Limited has informed the Exchange about Schedule of meet
  • Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Nov 2025, 6:03PM Accretion Pharmaceuticals Limited has informed the Exchange about Transcript
  • Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Nov 2025, 1:22PM Accretion Pharmaceuticals Limited has informed the Exchange about Link of Recording
  • Accretion Pharma - Investor Presentation

    17 Nov 2025, 8:31PM Accretion Pharmaceuticals Limited has informed the Exchange about Investor Presentation
  • Accretion Pharma - Press Release

    17 Nov 2025, 6:11PM Accretion Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 17, 2025, titled ""Media Release for the half yea
  • Accretion Pharma - Outcome of Board Meeting

    14 Nov 2025, 4:43PM Accretion Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
  • Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Nov 2025, 7:00PM Accretion Pharmaceuticals Limited has informed the Exchange about Schedule of meet
  • Accretion Pharma - General Updates

    28 Oct 2025, 5:40PM Accretion Pharmaceuticals Limited has informed the Exchange about General Updates
  • Accretion Pharma has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    22 Oct 2025, 8:50AM As of September 2025, 73.52% is owned by Indian Promoters and 26.48% by Public. <p align=justify> Top five Promoters holding highest number of shares
  • Accretion Pharma - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

    17 Oct 2025, 4:21PM Accretion Pharmaceuticals Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
  • Accretion Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    14 Oct 2025, 3:20PM Accretion Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Key fundamentals

Evaluate the intrinsic value of Accretion Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23
Assets 29.39 18.8298 12.3085
Liabilities 29.39 18.8298 12.3085
Equity 8.17 4 3.8427
Gross Profit 11.8808 7.4894 1.9913
Net Profit 6.7935 3.8753 0.1039
Cash From Operating Activities 5.7499 -3.8569 0.3212
NPM(%) 11.84 11.51 0.35
Revenue 57.3762 33.6652 29.3843
Expenses 45.4954 26.1758 27.393
ROE(%) 14.58 8.31 0.22

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Accretion Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 749.55 -1.88 0.00 0.00 301.39 0.67
Lotus Eye Hospital and Institute Ltd 115.48 -2.15 360.88 0.00 3.55 0.00
Vaishali Pharma Ltd 8.48 -2.42 0.00 0.00 3.13 0.00
Astec Lifesciences Ltd 664.80 -3.32 0.00 0.00 -604.77 0.00

Company Info

In the year 2012, our Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, with vision to provide health care products that match international quality standards at competitive price. Thus, the foundation of "Accretion Pharmaceuticals" was laid down, which was started as a Partnership Firm under the Partnership Act, 1932 ("Partnership Act") in the name and style of "M/s Accretion Pharmaceuticals", pursuant to a deed of partnership dated December 18, 2012. Our manufacturing facility which is currently located at 28 & 29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Vasna Chacharvadi, Ahmedabad, Sanand, Gujarat 382213, commenced its manufacturing operations in year 2014. Thereafter, pursuant to a resolution passed by the partners of M/s Accretion Pharmaceuticals on October 16, 2023, the Partnership Firm was converted into a Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of "Accretion Pharmaceuticals Limited" and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.The Corporate Identification Number of our Company is U21004GJ2023PLC146545.Major Events:2012- Formed as a Partnership Firm in the name and style of "M/s Accretion pharmaceuticals", pursuant to a deed of partnership dated December 18, 2012.2023-Incorporation of our Company "Accretion Pharmaceuticals Limited" as a Public Limited Company from conversion of "M/s Accretion Pharmaceuticals" a Partnership firm vide partner's resolution dated October 16, 2023.

In the year 2012, our Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, with vision to provide health care products that match international quality standards at competitive price. Thus, the foundation of "Accretion Pharmaceuticals" was laid down, which was started as a Partnership Firm under the Partnership Act, 1932 ("Partnership Act") in the name and style of "M/s Accretion Pharmaceuticals", pursuant to a deed of partnership dated December 18, 2012. Our manufacturing facility which is currently located at 28 & 29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Vasna Chacharvadi, Ahmedabad, Sanand, Gujarat 382213, commenced its manufacturing operations in year 2014. Thereafter, pursuant to a resolution passed by the partners of M/s Accretion Pharmaceuticals on October 16, 2023, the Partnership Firm was converted into a Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of "Accretion Pharmaceuticals Limited" and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.The Corporate Identification Number of our Company is U21004GJ2023PLC146545.Major Events:2012- Formed as a Partnership Firm in the name and style of "M/s Accretion pharmaceuticals", pursuant to a deed of partnership dated December 18, 2012.2023-Incorporation of our Company "Accretion Pharmaceuticals Limited" as a Public Limited Company from conversion of "M/s Accretion Pharmaceuticals" a Partnership firm vide partner's resolution dated October 16, 2023.

Read More

Parent Organisation

Accretion Pharmaceuticals Ltd.

Founded

18/12/2012

Managing Director

Mr.Vivek Ashok Kumar Patel

NSE Symbol

ACCPLST

FAQ

The current price of Accretion Pharmaceuticals Ltd is

The 52-week high for Accretion Pharmaceuticals Ltd is

The market capitalization of Accretion Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Accretion Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Accretion Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Accretion Pharmaceuticals Ltd shares.

The CEO of Accretion Pharmaceuticals Ltd is Mr.Vivek Ashok Kumar Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT